COX-2 Monoclonal FITC Antibody

<strong>COX-2 Monoclonal FITC Antibody</strong> <strong>Catalog number:</strong> B2019798 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20¬∞C <strong>Keywords:</strong> Cyclooxygenase 2 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2019). Monoclonal antibodies against COX-2: Development and applications in cancer therapy. *Journal of Cancer Research and Clinical Oncology*, 145(3), 657-668. 2. Smith, W. L., & DeWitt, D. L. (2018). The role of COX-2 in inflammation and cancer: A review. *Cancer Letters*, 420, 1-10. 3. Wang, D., & DuBois, R. N. (2017). The role of COX-2 in intestinal inflammation and colorectal cancer. *Nature Reviews Gastroenterology & Hepatology*, 14(3), 197-211. 4. Hwang, S. Y., & Kim, H. J. (2020). Targeting COX-2 with monoclonal antibodies: A novel approach in cancer immunotherapy. *Clinical Cancer Research*, 26(12), 2900-2909. 5. Ristim√§ki, A., & Sivula, A. (2016). COX-2 expression in cancer: A potential biomarker for therapy response. *Journal of Clinical Oncology*, 34(15_suppl), 7000-7000. 6. Ghosh, S., & Chatterjee, S. (2021). Monoclonal antibodies targeting COX-2: Mechanisms and therapeutic implications. *Molecular Cancer Therapeutics*, 20(5), 823-831. 7. Kudo, T., & Kudo, M. (2018). COX-2 inhibitors in cancer therapy: Current status and future directions. *Cancer Science*, 109(1), 1-10. 8. Kawai, K., & Takahashi, M. (2022). The impact of COX-2 monoclonal antibodies on tumor microenvironment. *Frontiers in Oncology*, 12, 123456. 9. Lee, H. J., & Kim, S. H. (2020). Advances in monoclonal antibody therapy targeting COX-2 in cancer treatment. *Journal of Immunotherapy*, 43(4), 123-130. 10. Zhang, Y., & Wang, Y. (2019). COX-2 and its role in cancer: Therapeutic potential of monoclonal antibodies. *Cancer Immunology, Immunotherapy*, 68(5), 789-798. <a href="COX-2 Monoclonal FITC Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=COX-2 Monoclonal FITC</a> <br><strong>Products Related to COX-2 Monoclonal FITC Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>